My account
Home
Push Notifications
Photo Gallery
EYE to EYE Las Vegas (Sept)
SECO 2026 >
SECO University >
Optometry News >
Archives >
Contact us
Important Info >
My Profile (optional)
Settings (clear caches)
ODCF
SECO International, LLC
ASRS 2026: MCO-010 optogenetic therapy sustains 3-line vision gains at 3 years in retinitis ...
Written on 07/21/2026
... regardless of gene mutation, with no
treatment
-related serious adverse events, per Benjamin Bakall, MD, PhD, at ASRS 2026.
Read full article
Share
post